| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 11 | |
| #2 | EPO (European Patent Office) | 4 | |
| #3 | WIPO (World Intellectual Property Organization) | 4 | |
| #4 | Australia | 3 | |
| #5 | Canada | 3 | |
| #6 | Argentina | 1 | |
| #7 | China | 1 | |
| #8 | EAPO (Eurasian Patent Organization) | 1 | |
| #9 | Hong Kong | 1 | |
| #10 | Mexico | 1 | |
| #11 | Singapore | 1 | |
| #12 | Taiwan | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Heterocyclic compounds | |
| #2 | Therapeutic chemical compounds | |
| #3 | Medical preparations |
| # | Name | Total Patents |
|---|---|---|
| #1 | Van Duzer John H | 25 |
| #2 | Mazitschek Ralph | 23 |
| #3 | Jarpe Matthew B | 8 |
| #4 | Blum Charles | 4 |
| #5 | Golonzhka Olga | 3 |
| #6 | Ralph Mazitschek | 2 |
| #7 | Heijnen Cobi J | 2 |
| #8 | Kavelaars Annemieke | 2 |
| #9 | John H Van Duzer | 2 |
| #10 | Krukowski Karen | 2 |
| Publication | Filing date | Title |
|---|---|---|
| WO2020076951A1 | Pyrimidine and pyrazine hdac1,2 inhibitors | |
| WO2020068950A1 | Hdac1,2 inhibitors | |
| CN110049978A | The alternatively bridged piperazine derivatives of property HDAC1,2 inhibitor | |
| US2017240535A1 | Hdac1/2 inhibitors for the treatment of neurodegenerative and/or cognitive disorders | |
| US2016346279A1 | Histone deacetylase 6 selective inhibitors for the treatment of cisplatin-induced peripheral neuropathy | |
| MX2017007623A | Piperidine derivatives as hdac1/2 inhibitors. |